ListarResources in English por tema "Lymphocytes"
Mostrando ítems 1-6 de 6
-
Dysregulation of immune response in patients with COVID-19 in Wuhan, China
(2020-03-12)[Conclusions] Of the 452 patients with COVID-19 recruited, 286 were diagnosed as severe infection. The median age was 58 years and 235 were male. The most common symptoms were fever, shortness of breath, expectoration, ... -
Hematological findings and complications of COVID‐19
(2020-04-13)COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio ... -
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19
(2020-04-03)[Abstract]. Background: Several studies have described the clinical characteristics of patients with novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19), indicating severe patients tended to have higher neutrophil ... -
Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis
(2020-04-03)To the Editor, Since March 11, 2020, the World Health Organization defined coronavirus disease 2019 (COVID‐19) as a pandemic, with a series of confirmed cases that currently exceeded 300,000 people worldwide and with ... -
Reactive lymphocytes in patients with Covid‐19
(2020-04-16)From January 23 to February 27, 2020, Singapore had 96 Covid‐19 cases confirmed by real time reverse transcriptase‐polymerase chain reaction (RT‐PCR) for SARS‐CoV‐2. We examined the peripheral blood films of 32 patients ... -
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients
(2020-04-16)We explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PII) and disease evolution in patients with (corona virus disease 2019) COVID‐19. A total of 123 patients with COVID‐19 ...